Predicting Extrapelvic Disease following primary radiation therapy for pros - Evidencio
Predicting Extrapelvic Disease following primary radiation therapy for prostate cancer
Anatomic patterns of recurrence in patients with a rising prostate-specific antigen after radiotherapy using C-11 choline positron emission tomography/computed tomography were identified. Most recurrences were localized to the pelvis and a tool was generated to aid in disease localization prior to evaluation with advanced imaging.

Note: The current model has not been externally validated. Only after additional validation, the model may prove to be useful for clinical decision making. 
Autores de la investigación: William P. Parker, Brian J. Davis, Sean S. Park, Kenneth R. Olivier, Richard Choo, Mark A. Nathan, Val J. Lowe, Timothy J. Welch, Jaden D. Evans, William S. Harmsen, Harras B. Zaid, Ilya Sobol, Daniel M. Moreira, Rimki Haloi, Matthew K. Tollefson, Matthew T. Gettman, Stephen A. Boorjian, Lance A. Mynderse, R. Jeffrey Karnes, Eugene D. Kwon
Versión: 1.6
  • Público
  • Urología
  • {{ modelType }}
  • Detalles
  • Validar algoritme
  • Guardar entrada
  • Entrada de carga
Mostrar
Unidades

{{ section.title }}

{{ section.description }}

Calcular el resultado

Establezca más parámetros para realizar el cálculo

Probability of extrapelvic recurrence is:

{{ resultSubheader }}
{{ $t('download_result_availability') }}
{{ chart.title }}
Intervalo de resultados {{ additionalResult.min }} a {{ additionalResult.max }}

Información condicional

The use of the current nomogram may be feasible to inform decisions on which patients should undergo further pelvic imaging and/or confrmatory biopsy before considering local salvage therapy. 

Note: The current model has not been externally validated. Only after additional validation, the model may prove to be useful for clinical decision making. 

 

{{ file.classification }}
PRO
Nota
Las notas sólo son visibles en la descarga de resultados y no serán guardadas por Evidencio

Este algoritme se proporciona con fines educativos, formativos e informativos. No debe utilizarse para apoyar la toma de decisiones médicas ni para prestar servicios médicos o de diagnóstico. Lea nuestro disclaimer.

Algoritmer subyacentes Parte de
Comentarios
Comentario
Escriba un comentario
Los comentarios son visibles para cualquiera

Comentarios sobre el algoritme

Aún no hay comentarios 1 comentario {{ model.comments.length }} Comentarios
En {{ comment.created_at }} {{ comment.user.username }} un autor ya no registrado escribió:
{{ comment.content }}
logo

Inicia sesión para activar las funciones de impresión de Evidencio

Para poder utilizar las funciones de impresión de Evidencio, debe estar conectado.
Si no tiene una cuenta de la Comunidad Evidencio puede crear su cuenta personal gratuita en:

https://www.evidencio.com/registration

Resultados impresos - Ejemplos {{ new Date().toLocaleString() }}


Beneficios de la Cuenta Comunitaria Evidencio


With an Evidencio Community account you can:

  • Create and publish your own prediction algorithms.
  • Share your prediction algorithms with your colleagues, research group, organization or the world.
  • Review and provide feedback on algorithms that have been shared with you.
  • Validate your algorithms and validate algorithms from other users.
  • Find algorithms based on Title, Keyword, Author, Institute, or MeSH classification.
  • Use and save prediction algorithms and their data.
  • Use patient specific protocols and guidelines based on sequential algorithms and decision trees.
  • Stay up-to-date with new algorithms in your field as they are published.
  • Create your own lists of favorite algorithms and topics.

A personal Evidencio account is free, with no strings attached!
Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction algorithms.


Descargo de responsabilidad: Los cálculos por sí solos nunca deben dictar la atención al paciente, y no sustituyen al juicio profesional.
Evidencio v3.38 © 2015 - 2025 Evidencio. Todos los derechos reservados